NCT03572673

Brief Summary

To compare the performance of the comparator Flexima 3S appliance to a new 2-piece appliance in patients with enterostomy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2018

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2018

Completed
15 days until next milestone

Study Start

First participant enrolled

May 8, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 28, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

June 28, 2018

Status Verified

June 1, 2018

Enrollment Period

11 months

First QC Date

April 23, 2018

Last Update Submit

June 19, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in base plate wear time, on average every 5 days, up to 21 (±3) days, for each study period

    For each base plate, the wear time will be evaluated during 21 (±3) days

    On average every 5 days, up to 21 (±3) days for each period

Secondary Outcomes (6)

  • Assessment of the condition of peristomal skin

    After base plate removal at protocol visit 1 (day 0) and visit 2 (at 21 (±3) days)

  • Assessment of the main reason of base plate removal

    From date of randomization, on average every 5 days, after each base plate removal, up to 21 (±3) days for each study period

  • Assessment of acceptability

    At the end of each study period (21 (±3) days), at visit 2 (21 (±3) days) and at visit 3 (42 (±6) days)

  • Assessment of use of accessories

    From date of randomization, on average every 5 days, after each base plate removal, up to 21 (±3) days for each study period

  • Preference between Flexima® 3S and the new 2-piece ostomy appliance

    At the end of the study, at 42 (±6) days

  • +1 more secondary outcomes

Study Arms (2)

Flexima 3S

ACTIVE COMPARATOR

Flexima 3S is a 2-piece ostomy appliance composed with an adhesive base plate and a drainable pouch for collecting stools (1 base plate for 5 days and 1 pouch for 5 days)

Device: Flexima 3S

New 2-piece ostomy appliance

EXPERIMENTAL

New 2-piece appliance is a 2-piece ostomy appliance composed with an adhesive base plate and a drainable pouch for collecting stools (1 base plate for 5 days and 1 pouch for 5 days)

Device: New 2-piece ostomy appliance

Interventions

Flexima 3S (2-piece appliance) with drainable pouch

Also known as: Class 1 appliance for patients having an enterostoma
Flexima 3S

New 2-piece ostomy appliance with drainable pouch

Also known as: Class 1 appliance for patients having an enterostoma
New 2-piece ostomy appliance

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient having a colostomy or an ileostomy for at least 1 month
  • patient currently using a flat appliance
  • patient wearing his appliance, on average, at least 5 days
  • patient with a stoma's diameter less than 65 mm
  • patient who agrees to participate in the evaluation and who have signed the inform consent
  • patient having a mental capacity to participate to the study (i.e. to understand the study and to answer to the questions)

You may not qualify if:

  • Patient receiving or having received, within the last month, chemotherapy or corticotherapy
  • Patient already participating in another clinical study or who have previously participated in this investigation
  • Pregnant or breast-feeding woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hospital Selayang

Batu Caves, 68100, Malaysia

RECRUITING

Hospital Canselor Tuanku Muhriz

Kuala Lumpur, 56000, Malaysia

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2018

First Posted

June 28, 2018

Study Start

May 8, 2018

Primary Completion

April 1, 2019

Study Completion

April 1, 2019

Last Updated

June 28, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share

Locations